D-PRISM (Precision Intervention Smoldering Myeloma) A Phase II Study of the CD38 Antibody Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

NOT ENROLLING

877-DF-TRIAL (877-338-7425)

Trial ID:

NCT03236428

View Complete trial on ClinicalTrials.gov

Protocol # :

17-212

Phase

II

Disease Sites

Other Hematopoietic

Multiple Myeloma

Principal Investigator

Ghobrial, Irene, M

Site Investigator

Rosenblatt, Jacalyn

Yee, Andrew

Site Research Nurses

Accumanno, Chelsea

Amweg, Laura, N.

Babcock, Elise

Barrell, Anna

Bright, Susan

Colson, Kathleen, A.

Cummings, Kristen

Davie, Christine, M.

Dipietro, Heidi, L.

Frey, Erin

Gammon, Marilyn

Guimond, Kathleen

Harran, John

Kendricken, Elizabeth

Knudsen, Elisabeth

Lively, Kathleen, J.

Logan, Emma, Kristen

Metivier, Amada

Nutter, Meredith, Elise

O'Brien, Alexandra

Silva, Wendy, Ann

Spillane, Kerry, L.

Trial Description

Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #17-212

17-212